Merck Buys Imago for $1.35B to Gain Marrow Drugs
The purchase is part of Merck’s search for more treatments for cancer and rare diseases.
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.